• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC, INC. VIVA QUAD XT; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC, INC. VIVA QUAD XT; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO Back to Search Results
Model Number DTBA2QQ
Device Problems Failure to Capture (1081); Over-Sensing (1438)
Patient Problem Heart Failure (2206)
Event Date 12/15/2015
Event Type  Injury  
Manufacturer Narrative
Concomitant product: 4298-88 atrial lead.This information is based entirely on journal literature.This event occurred outside the us.All information provided is included in this report.Patient information is limited due to confidentiality concerns.Without a lot number or device serial number, the manufacturing date cannot be determined.Since no device id was provided, it is unknown if this event has been previously reported.A request for additional information will be made and upon receipt a supplemental report will be submitted accordingly.Referenced article: device rounds: t-wave oversensing: a cause of loss of cardiac resynchronization therapy.Indian pacing and electrophysiology journal.2016;16(5):175-178.
 
Event Description
A journal article was reviewed which contained information regarding this patient¿s implantable cardiac resynchronisation therapy with defibrillator (crt-d) system.The article reported that the patient presented with loss of biventricular pacing associated with heart failure symptoms.The electrocardiogram showed sinus rhythm with alternating wide unpaced and narrower paced qrs complexes.Device interrogation showed t-wave oversensing (twos) on all paced biventricular beats.Device reprogramming resolved the twos.At the three-month check-up, the patient¿s hf symptoms had improved.The system remains in use.Further follow up did not yet yield any additional information.No further patient complications have been reported as a result of this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIVA QUAD XT
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO
Manufacturer (Section D)
MEDTRONIC, INC.
8200 coral sea street ne
mounds view MN 55112
Manufacturer (Section G)
MEDTRONIC, INC.
8200 coral sea street ne
mounds view MN 55112
Manufacturer Contact
anne schilling
8200 coral sea st ne
mounds view, MN 55112
7635052036
MDR Report Key6468470
MDR Text Key72077699
Report Number2182208-2017-00534
Device Sequence Number1
Product Code NIK
Combination Product (y/n)N
Reporter Country CodeSZ
PMA/PMN Number
P010031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 01/06/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/06/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberDTBA2QQ
Device Catalogue NumberDTBA2QQ
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/06/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
6935 IMPLANTABLE TACHY LEAD
Patient Outcome(s) Required Intervention;
Patient Age78 YR
-
-